Please login to the form below

Not currently logged in
Email:
Password:

Joel Colwell moves from Sanofi to J+D Consulting

He will support the firm’s senior team across their projects

Joel ColwellJ+D Consulting, a specialised healthcare consultancy, has appointed Joel Colwell to its team.

Previously at Sanofi, Colwell joins the firm as they prepare to launch new projects, which he will support, with a particular focus on forecasting and insight generation.

David James, chief executive officer of J+D Consulting, said: “Joel brings a broad skill set to J+D and he will certainly add value to both our business that of our clients.”

Colwell said: “J+D have some great new products that will make forecasting so much easier for clients and I’m really looking forward to seeing these in action.

“I knew the team cared about how they supported clients and I see they truly live and breathe every tool they develop to make it the best it can be, it’s an exciting place to be right now.”

29th January 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget....
Innovative approaches in the treatment of multiple sclerosis
Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon....

Infographics